Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$795,942
-$82,089 QoQ
Shares Held
6,300
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,169
of 2,266 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLOUGH CAPITAL PARTNERS L P holds $44,798,668 across 4 Drug Manufacturers - General names. GILD ranks #3 (1.8% of the industry book) .
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $795,942 | 6,300 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $878,031 | 6,300 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $773,262 | 6,300 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $699,300 | 6,300 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $698,481 | 6,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $705,915 | 6,300 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $581,931 | 6,300 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $528,192 | 6,300 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $432,243 | 6,300 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $461,475 | 6,300 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $510,363 | 6,300 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $577,038 | 7,700 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $593,439 | 7,700 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $638,869 | 7,700 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $661,045 | 7,700 | Shares | Defined | 2023-02-14 | |
| 2020-06-30 | $7,940,208 | 103,200 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,980,120 | 187,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||